StonvexLoading…
StonvexStonvexStonvexCore line items from AMN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $1.38B | $2.73B | $1.98B | $1.35B |
Operating Income | $117.17M | $-55.47M | $-63.59M | $-111.21M |
Net Income | $62.17M | $-95.70M | $-88.01M | $-117.29M |
EPS (Diluted) | $1.59 | $-2.48 | $-2.29 | $-3.06 |
Total Assets | $2.60B | $2.09B | $2.14B | $2.21B |
Total Liabilities | $1.89B | $1.45B | $1.49B | $1.60B |
Cash & Equivalents | $560.74M | $33.97M | $52.64M | $41.50M |
Free Cash Flow OCF − CapEx | $555.21M | $233.83M | $166.20M | $151.44M |
Shares Outstanding | 38.66M | 38.44M | 38.33M | 38.30M |